Dosis announces nationwide precision dosing implementation with davita

San francisco--(business wire)--dosis, a market leader in artificial intelligence-powered precision dosing, announced today the implementation of its flagship personalized dosing product at davita (nyse: dva) clinics nationwide. dosis's smart anemia manager (sam) personalizes drug dosing for erythropoiesis-stimulating agents (esas), a class of drugs used to treat end-stage renal disease patients with chronic anemia. integration of dosis's personalized dosing recommendations into davita's anemia
DVA Ratings Summary
DVA Quant Ranking